 NAVB | Navidea Biopharmaceuticals, Inc. Company profile
Company profileNavidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Applying our Manocept? technology, Navidea seeks to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. The company, founded in 1983, maintains headquarters in Dublin, Ohio.
Address4995 Bradenton Avenue | NotesJump to (Finance sites)         ResearchInvestor pageir.navidea.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Their Official Profiles Peers / Similar stocks Other stocks            Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949. The best book on investing ever written. |